INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding

BACKGROUND: Bleeding is the most common adverse event in those with cardiovascular (CV) disease receiving antithrombotic therapy, and it most commonly occurs in the gastrointestinal (GI) tract. Clinicians often dismiss bleeding as an adverse event that is reversible with effective antithrombotic the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Jacqueline, Moayyedi, Paul, Alings, Marco, Avezum, Alvaro, Bangdiwala, Shrikant I., Barkun, Alan, Cassella, Federico, Marchi da Rocha, Aloisio, Duzen, Irfan, Enns, Robert, Forbes, Nauzer, Hamilton, Leah, Islam, Shofiqul, Kilickap, Mustafa, Kruger, Paul, Liang, Yan, Nicolau, Jose C., Nunes, Rafael, O’Donnell, Martin, Oliveira, Gustavo, Rey, Alejandro, Sun, Yihong, Vanassche, Thomas, Verhamme, Peter, Walsh, Michael, Wang, Zhenyu, Wu, Cynthia, Zhao, Li, Zhu, Jun, Eikelboom, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700215/
https://www.ncbi.nlm.nih.gov/pubmed/36444363
http://dx.doi.org/10.1016/j.cjco.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700215/
https://www.ncbi.nlm.nih.gov/pubmed/36444363
http://dx.doi.org/10.1016/j.cjco.2022.08.002

Ejemplares similares